(Reuters) – The European health regulator on Thursday endorsed the authorization of booster doses of the Pfizer/BioNTech COVID-19 vaccine for use in adolescents aged 12 and over.
The agency also recommended the approval of Moderna’s vaccine for use in children aged six to 11 years of age.
(Reporting by Manojna Maddipatla in Bengaluru; Editing by Alison Williams)
